risks Archives - WinWay Health Blog

health remedies

ESC: Pfizer, BMS’ Eliquis tops Xarelto, vitamin K drugs for site-specific...

Winway Health Desk - August 29, 2020

Pfizer and Bristol Myers Squibb's anticoagulant superstar Eliquis has raced out to blockbuster sales in recent years and a big-time lead over its its...

Philips acquires Boston patient management startup Medumo

Winway Health Desk - July 21, 2019

Seton Opens $30M Neighborhood Hospital In Bastrop

Winway Health Desk - December 19, 2019

FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents

Winway Health Desk - March 17, 2019

Analyzing CVS Health’s $8B buy: There’s no place like home

Winway Health Desk - September 6, 2022

Tag: risks

ESC: Pfizer, BMS’ Eliquis tops Xarelto, vitamin K drugs for site-specific...

EDITOR PICKS

Philips acquires Boston patient management startup Medumo

Seton Opens $30M Neighborhood Hospital In Bastrop

FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents

Analyzing CVS Health’s $8B buy: There’s no place like home

EVEN MORE NEWS

Glen Tullman Has ‘No Interest’ In Selling Transcarent, But IPO Is...

Navigating the Complexities of Payment for Genetic Testing

FDA Grants First-Ever Approval to an RNA-Based Diagnostic for Colorectal Cancer

POPULAR CATEGORY